Serum Opacity Factor Enhances HDL‐Mediated Cholesterol Efflux, Esterification and Anti Inflammatory Effects
Abstract
Serum opacity factor (SOF) is a streptococcal protein that disrupts the structure of human high density lipoproteins (HDL) releasing lipid‐free apo A‐I while forming a large cholesteryl ester‐rich particle and a small neo HDL. Given its low cholesterol and high phospholipid contents, we tested the hypotheses that neo HDL is a better substrate for cholesterol esterification via lecithin:cholesterol acyltransferase (LCAT), better than HDL as an acceptor of THP‐1 macrophage cholesterol efflux, and improves reduction of oxidized LDL‐induced production of inflammatory markers. We observed that both cholesterol efflux and esterification were improved by recombinant (r)SOF treatment of whole plasma and that the underlying cause of the improved cholesterol esterification in plasma and macrophage cholesterol efflux to rSOF‐treated plasma was due to the rSOF‐mediated conversion of HDL to neo HDL. Moreover, the reduction of secretion of TNF‐α and IL‐6 by THP‐1 cells by neo HDL was twice that of HDL. Studies in BHK cells overexpressing cholesterol transporters showed that efflux to neo HDL occurred primarily via ABCA1 not ABCG1. Thus, rSOF improves two steps in reverse cholesterol transport with a concomitant reduction in the release of macrophage markers of inflammation. We conclude that rSOF catalyzes a novel reaction that might be developed as a new therapy that prevents or reverses atherosclerosis via improved reverse cholesterol transport.Keywords
Funding Information
- National Institutes of Health (HL‐30914, HL‐56865)
This publication has 38 references indexed in Scilit:
- Streptococcal Serum Opacity Factor Increases the Rate of Hepatocyte Uptake of Human Plasma High-Density Lipoprotein CholesterolBiochemistry, 2010
- The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- HDL superphospholipidation enhances key steps in reverse cholesterol transportAtherosclerosis, 2010
- Lecithin: Cholesterol Acyltransferase Expression Has Minimal Effects on Macrophage Reverse Cholesterol Transport In VivoCirculation, 2009
- Disruption of Human Plasma High-Density Lipoproteins by Streptococcal Serum Opacity Factor Requires Labile Apolipoprotein A-IBiochemistry, 2009
- Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol effluxJournal of Lipid Research, 2009
- Properties of the products formed by the activity of serum opacity factor against human plasma high-density lipoproteinsChemistry and Physics of Lipids, 2008
- Characterization and properties of preβ-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-IJournal of Lipid Research, 2008
- Serum Opacity Factor Unmasks Human Plasma High-Density Lipoprotein Instability via Selective Delipidation and Apolipoprotein A-I DesorptionBiochemistry, 2007
- Detergent-Mediated Phospholipidation of Plasma Lipoproteins Increases HDL Cholesterophilicity and Cholesterol Efflux via SR-BIBiochemistry, 2006